Is Utah Medical Stock a Good Investment?
Utah Medical Investment Advice | UTMD |
- Examine Utah Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Utah Medical's leadership team and their track record. Good management can help Utah Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Utah Medical's business and its evolving consumer preferences.
- Compare Utah Medical's performance and market position to its competitors. Analyze how Utah Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Utah Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Utah Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Utah Medical Products stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Utah Medical Products is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Utah Medical Stock
Researching Utah Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 71.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.62. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Utah Medical Products last dividend was issued on the 14th of March 2025. The entity had 3:2 split on the 22nd of March 1993.
To determine if Utah Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Utah Medical's research are outlined below:
| Utah Medical generated a negative expected return over the last 90 days | |
| About 71.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Insider Trading |
Utah Medical Quarterly Accounts Payable |
|
Utah Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Utah Medical Products. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Utah Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 23rd of April 2024 Upcoming Quarterly Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View |
Know Utah Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Utah Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Utah Medical Products backward and forwards among themselves. Utah Medical's institutional investor refers to the entity that pools money to purchase Utah Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Minerva Advisors Llc | 2024-12-31 | 78.4 K | Hotchkis & Wiley Capital Management Llc | 2024-12-31 | 75.2 K | Bank Of New York Mellon Corp | 2024-12-31 | 47.3 K | Acadian Asset Management Llc | 2024-12-31 | 43.2 K | Royce & Associates, Lp | 2024-12-31 | 42 K | Northern Trust Corp | 2024-12-31 | 36.8 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 36.4 K | Millennium Management Llc | 2024-12-31 | 32.1 K | Isthmus Partners Llc | 2024-12-31 | 31.5 K | Renaissance Technologies Corp | 2024-12-31 | 221.5 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 186.7 K |
Utah Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 190.24 M.Market Cap |
|
Utah Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.13 | 0.12 | |
| Return On Capital Employed | 0.11 | 0.11 | |
| Return On Assets | 0.11 | 0.20 | |
| Return On Equity | 0.12 | 0.11 |
Determining Utah Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Utah Medical is a good buy. For example, gross profit margin measures Utah Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Utah Medical's profitability and make more informed investment decisions.
Please note, the presentation of Utah Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Utah Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Utah Medical's management manipulating its earnings.
Evaluate Utah Medical's management efficiency
Utah Medical Products has return on total asset (ROA) of 0.0762 % which means that it generated a profit of $0.0762 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1129 %, meaning that it created $0.1129 on every $100 dollars invested by stockholders. Utah Medical's management efficiency ratios could be used to measure how well Utah Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Assets is expected to grow to 0.20, whereas Return On Tangible Assets are forecasted to decline to 0.12. At present, Utah Medical's Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 101.1 M, whereas Other Current Assets are forecasted to decline to about 425.6 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 33.52 | 35.20 | |
| Tangible Book Value Per Share | 28.83 | 30.27 | |
| Enterprise Value Over EBITDA | 7.17 | 11.20 | |
| Price Book Value Ratio | 1.83 | 1.74 | |
| Enterprise Value Multiple | 7.17 | 11.20 | |
| Price Fair Value | 1.83 | 1.74 | |
| Enterprise Value | 192.4 M | 202 M |
Utah Medical Products has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Basic technical analysis of Utah Stock
As of the 25th of March, Utah Medical has the Risk Adjusted Performance of (0.14), variance of 0.8054, and Coefficient Of Variation of (654.60). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Utah Medical Products, as well as the relationship between them. Please validate Utah Medical Products mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Utah Medical is priced more or less accurately, providing market reflects its prevalent price of 56.85 per share. Given that Utah Medical Products has information ratio of (0.12), we advise you to double-check Utah Medical Products's current market performance to make sure the company can sustain itself at a future point.Utah Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Utah Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Utah Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Utah Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Leigh Carrie 19 hours ago Insider Trading | ||
Leigh Carrie a day ago Insider Trading | ||
Leigh Carrie 2 days ago Insider Trading | ||
Leigh Carrie 3 days ago Insider Trading | ||
Leigh Carrie few days ago Insider Trading | ||
Leigh Carrie few days ago Insider Trading | ||
Leigh Carrie six days ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading |
Utah Medical's Outstanding Corporate Bonds
Utah Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Utah Medical Products uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Utah bonds can be classified according to their maturity, which is the date when Utah Medical Products has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| USA Compression Partners Corp BondUS91740PAF53 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Utah Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Utah Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.14) | |||
| Market Risk Adjusted Performance | (0.34) | |||
| Mean Deviation | 0.6434 | |||
| Coefficient Of Variation | (654.60) | |||
| Standard Deviation | 0.8975 | |||
| Variance | 0.8054 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.11) | |||
| Treynor Ratio | (0.35) | |||
| Maximum Drawdown | 4.92 | |||
| Value At Risk | (1.72) | |||
| Potential Upside | 1.1 | |||
| Skewness | 0.0155 | |||
| Kurtosis | 1.24 |
| Risk Adjusted Performance | (0.14) | |||
| Market Risk Adjusted Performance | (0.34) | |||
| Mean Deviation | 0.6434 | |||
| Coefficient Of Variation | (654.60) | |||
| Standard Deviation | 0.8975 | |||
| Variance | 0.8054 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.11) | |||
| Treynor Ratio | (0.35) | |||
| Maximum Drawdown | 4.92 | |||
| Value At Risk | (1.72) | |||
| Potential Upside | 1.1 | |||
| Skewness | 0.0155 | |||
| Kurtosis | 1.24 |
Consider Utah Medical's intraday indicators
Utah Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Utah Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 160.16 | |||
| Daily Balance Of Power | (0.26) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 57.11 | |||
| Day Typical Price | 57.02 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (0.35) | |||
| Period Momentum Indicator | (0.19) |
Utah Medical Corporate Filings
| 5th of February 2025 Other Reports | ViewVerify | |
8K | 28th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 12th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 8th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Utah Stock media impact
Far too much social signal, news, headlines, and media speculation about Utah Medical that are available to investors today. That information is available publicly through Utah media outlets and privately through word of mouth or via Utah internal channels. However, regardless of the origin, that massive amount of Utah data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Utah Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Utah Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Utah Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Utah Medical alpha.
Utah Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Utah Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Dividend Share 1.205 | Earnings Share 3.96 | Revenue Per Share | Quarterly Revenue Growth (0.26) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Utah Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.